Common questions about TMS

TMS is a non-invasive treatment that uses magnetic pulses to stimulate brain areas involved in mood regulation. Crane River TMS uses Magstim technology.

Our primary focus is adults with major depressive disorder, often when medication and psychotherapy have not provided satisfactory improvement. Eligibility requires clinical and safety evaluation.

OCD, PTSD, and other conditions may be discussed. Appropriateness, protocol availability, and insurance coverage are evaluated individually.

You may hear clicking and feel tapping on the scalp. Some patients experience temporary scalp discomfort or headache.

Initial mapping takes approximately 45 minutes. A typical course includes 30–36 treatment days at approximately 20 minutes per regular session.

Many commercial plans and Medicare may cover medically necessary treatment after prior authorization. Medicaid does not cover TMS through our clinic at this time.

Scalp discomfort and headache are among the more common short-term effects. Some people also notice temporary facial muscle twitching or lightheadedness. Seizure is rare but is an important risk to discuss during screening. Tell the team about any new or troublesome symptoms.

Tell your provider about any history of seizures, head injury, or medical conditions that may affect seizure risk, and about metal or electronic devices in or near the head. The provider will review the specific device and treatment protocol before deciding whether TMS is appropriate.

TMS does not normally require anesthesia or sedation. Most patients can return to their usual activities after a treatment session, unless their clinician gives different advice based on their circumstances.

TMS may be part of a broader treatment plan that includes medication or psychotherapy. Tell your provider about all medications and any changes; do not stop or adjust medication without speaking with your prescriber.

Responses vary. Some patients notice changes during the course of treatment, while others do not notice improvement until later. Your team will monitor symptoms over time; an individual result cannot be predicted in advance.

Duration of benefit varies. Your clinician can discuss follow-up care and options if symptoms return. Additional TMS may be considered for some people after a new evaluation, and insurance requirements may differ.

A trained team member guides each treatment visit, and your Crane River TMS provider oversees the treatment plan and reviews progress. Ask the clinic how often you will meet with the provider during your own course.

The team determines the treatment location and individual stimulation settings before regular sessions begin. Plan for approximately 45 minutes for this appointment, though timing can vary.

Because standard TMS does not use sedation, many people can drive afterward. If you feel unwell or receive different instructions from your clinician, follow the team’s advice.

See the National Institute of Mental Health overview, FDA rTMS device guidance, and Magstim’s patient education page. Your clinical team can explain how these general descriptions apply to your treatment.